Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 27, 2024Anticancer ResearchOpen Access

Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience

View Full Paper
Ask AI
Bookmark
Share

Authors

YBYuta BabaNHNoriko HidaTSTakehiko Sambe

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Baba et al. (2024) studied this question.

synapsesocial.com/papers/68e6d425b6db643587651a63https://doi.org/10.21873/anticanres.17003
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Addition of Venetoclax to Azacitidine Did Not Improve Survival in Acute Myeloid Leukemia and Was Not Well Tolerated: Real World Experience2026
  2. 2Real-life multicenter experience of long-term treatment with venetoclax plus azacitidine for acute myeloid leukemia in China2026
  3. 3Real World Experience of Azacitidine + Venetoclax in AML rigorously following management guidelines from clinical trial2025
  4. 4Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience2024 · 12 citations
  5. 5Safety and efficacy of semi-dose venetoclax plus azacitidine in unfit acute myeloid leukemia patients in China: a real-world single-center study2025 · 2 citations